China begins to unravel regulatory maze with new agency
This article was originally published in Clinica
China is to have a new, single regulatory agency with responsibility for medical devices, pharmaceuticals and traditional medicines. The new agency, tentatively called the State Drug Administration of China, will start work next month and report directly to the State Council.
You may also be interested in...ï»¿
Informa Pharma Intelligence has officially launched the seventh Global Generics & Biosimilars Awards, which will take place in October 2020 in Milan, Italy.
Hours before the US FDA confirmed the first drug shortage due to active pharmaceutical ingredient constraints because of the coronavirus situation in China, generics industry leader Mylan came under pressure about the potential impact on its business.
Government advisory committee gives initial nod to what will become Japan’s most expensive single drug, but reimbursement pricing could come in for close scrutiny.